BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

918 related articles for article (PubMed ID: 18455343)

  • 1. Chemistry of paramagnetic and diamagnetic contrast agents for Magnetic Resonance Imaging and Spectroscopy pH responsive contrast agents.
    Pérez-Mayoral E; Negri V; Soler-Padrós J; Cerdán S; Ballesteros P
    Eur J Radiol; 2008 Sep; 67(3):453-8. PubMed ID: 18455343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pushing the sensitivity envelope of lanthanide-based magnetic resonance imaging (MRI) contrast agents for molecular imaging applications.
    Aime S; Castelli DD; Crich SG; Gianolio E; Terreno E
    Acc Chem Res; 2009 Jul; 42(7):822-31. PubMed ID: 19534516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contrast agents: magnetic resonance.
    Burtea C; Laurent S; Vander Elst L; Muller RN
    Handb Exp Pharmacol; 2008; (185 Pt 1):135-65. PubMed ID: 18626802
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lanthanide(III) complexes that contain a self-immolative arm: potential enzyme responsive contrast agents for magnetic resonance imaging.
    Chauvin T; Torres S; Rosseto R; Kotek J; Badet B; Durand P; Tóth E
    Chemistry; 2012 Jan; 18(5):1408-18. PubMed ID: 22213022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Water-soluble gadofullerenes: toward high-relaxivity, pH-responsive MRI contrast agents.
    Tóth E; Bolskar RD; Borel A; González G; Helm L; Merbach AE; Sitharaman B; Wilson LJ
    J Am Chem Soc; 2005 Jan; 127(2):799-805. PubMed ID: 15643906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Macrocyclic Gd3+ chelates attached to a silsesquioxane core as potential magnetic resonance imaging contrast agents: synthesis, physicochemical characterization, and stability studies.
    Henig J; Tóth E; Engelmann J; Gottschalk S; Mayer HA
    Inorg Chem; 2010 Jul; 49(13):6124-38. PubMed ID: 20527901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Separation and characterization of the two diastereomers for [Gd(DTPA-bz-NH2)(H2O)]2-, a common synthon in macromolecular MRI contrast agents: their water exchange and isomerization kinetics.
    Burai L; Tóth E; Sour A; Merbach AE
    Inorg Chem; 2005 May; 44(10):3561-8. PubMed ID: 15877439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Gd3+-based magnetic resonance imaging contrast agent sensitive to beta-galactosidase activity utilizing a receptor-induced magnetization enhancement (RIME) phenomenon.
    Hanaoka K; Kikuchi K; Terai T; Komatsu T; Nagano T
    Chemistry; 2008; 14(3):987-95. PubMed ID: 17992679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dynamics of paramagnetic agents by off-resonance rotating frame technique.
    Zhang H; Xie Y
    J Magn Reson; 2006 Dec; 183(2):213-27. PubMed ID: 16979920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Basic principles of magnetic resonance contrast agents.
    Kirsch JE
    Top Magn Reson Imaging; 1991 Mar; 3(2):1-18. PubMed ID: 2025431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amplification strategies in MR imaging: activation and accumulation of sensing contrast agents (SCAs).
    Querol M; Bogdanov A
    J Magn Reson Imaging; 2006 Nov; 24(5):971-82. PubMed ID: 17024658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lanthanide complexes of triethylenetetramine tetra-, penta-, and hexaacetamide ligands as paramagnetic chemical exchange-dependent saturation transfer contrast agents for magnetic resonance imaging: nona- versus decadentate coordination.
    Burdinski D; Pikkemaat JA; Lub J; de Peinder P; Nieto Garrido L; Weyhermüller T
    Inorg Chem; 2009 Jul; 48(14):6692-712. PubMed ID: 19507818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lanthanide chelates of (bis)-hydroxymethyl-substituted DTTA with potential application as contrast agents in magnetic resonance imaging.
    Silvério S; Torres S; Martins AF; Martins JA; André JP; Helm L; Prata MI; Santos AC; Geraldes CF
    Dalton Trans; 2009 Jun; (24):4656-70. PubMed ID: 19513474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and characterization of PEGylated Gd2O3 nanoparticles for MRI contrast enhancement.
    Ahrén M; Selegård L; Klasson A; Söderlind F; Abrikossova N; Skoglund C; Bengtsson T; Engström M; Käll PO; Uvdal K
    Langmuir; 2010 Apr; 26(8):5753-62. PubMed ID: 20334417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rotational dynamics account for pH-dependent relaxivities of PAMAM dendrimeric, Gd-based potential MRI contrast agents.
    Laus S; Sour A; Ruloff R; Tóth E; Merbach AE
    Chemistry; 2005 May; 11(10):3064-76. PubMed ID: 15776490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relaxometric evaluation of novel manganese(II) complexes for application as contrast agents in magnetic resonance imaging.
    Aime S; Anelli L; Botta M; Brocchetta M; Canton S; Fedeli F; Gianolio E; Terreno E
    J Biol Inorg Chem; 2002 Jan; 7(1-2):58-67. PubMed ID: 11862541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design of Gd(III)-based magnetic resonance imaging contrast agents: static and transient zero-field splitting contributions to the electronic relaxation and their impact on relaxivity.
    Benmelouka M; Borel A; Moriggi L; Helm L; Merbach AE
    J Phys Chem B; 2007 Feb; 111(4):832-40. PubMed ID: 17249827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cerebral blood volume quantification in a C6 tumor model using gadolinium per (3,6-anhydro) alpha-cyclodextrin as a new magnetic resonance imaging preclinical contrast agent.
    Lahrech H; Perles-Barbacaru AT; Aous S; Le Bas JF; Debouzy JC; Gadelle A; Fries PH
    J Cereb Blood Flow Metab; 2008 May; 28(5):1017-29. PubMed ID: 18183033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Osmotically shrunken LIPOCEST agents: an innovative class of magnetic resonance imaging contrast media based on chemical exchange saturation transfer.
    Terreno E; Delli Castelli D; Violante E; Sanders HM; Sommerdijk NA; Aime S
    Chemistry; 2009; 15(6):1440-8. PubMed ID: 19115311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The gadolinium(III)-water hydrogen distance in MRI contrast agents.
    Caravan P; Astashkin AV; Raitsimring AM
    Inorg Chem; 2003 Jun; 42(13):3972-4. PubMed ID: 12817950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 46.